Table 2.
Variable comparison between groups 3 months’ follow-up
| Variables | Active (n = 52) | Controlled (n = 56) |
|---|---|---|
| Age (years) | 43.7 ± 5.2 | 44.9 ± 6.0 |
| Male, n (%) | 28 (53.8) | 31 (55.4) |
| BMI (kg/m2) | 23.1 ± 3.5 | 24.2 ± 4.6 |
| Overweight, n (%)* | 5 (9.6) | 10 (17.9) |
| Obese, n (%) | 5 (9.6) | 5 (8.9) |
| Waist circumference (cm) | 81.2 ± 5.2 | 82.2 ± 7.6 |
| Smoking, n (%) | 18 (34.6) | 18 (32.1) |
| Hypertension, n (%) | 13 (25.0) | 13 (23.2) |
| Dyslipidemia, n (%) | 15 (28.8) | 16 (28.6) |
| SBP (mmHg) | 120.5 ± 11.7 | 122.4 ± 11.3 |
| DBP (mmHg) | 75.4 ± 7.8 | 75.1 ± 9.0 |
| HR (bpm) | 70.3 ± 8.3 | 73.1 ± 7.6 |
| TG (mmol/L) | 1.6 ± 0.3 | 1.8 ± 0.3 |
| TC (mmol/L) | 5.1 ± 0.5 | 5.5 ± 0.4 |
| LDL-C (mmol/L) | 3.2 ± 0.3 | 3.4 ± 0.4 |
| HDL-C (mmol/L) | 1.2 ± 0.2 | 1.1 ± 0.3 |
| Lp(a) (mg/L)* | 109.6 ± 10.7 | 121.3 ± 12.4 |
| FBG (mmol/L) | 6.0 ± 0.3 | 6.3 ± 0.5 |
| HbA1c (%) | 5.4 ± 0.4 | 5.6 ± 0.3 |
| Cr (μmol/L) | 95.4 ± 10.3 | 99.7 ± 9.2 |
| BUN (mmol/L) | 5.7 ± 1.1 | 5.9 ± 1.0 |
| Hs-CRP (mg/L)* | 3.4 ± 0.7 | 4.9 ± 1.1 |
| ROCK2 activity (mg/mL)* | 40.6 ± 5.3 | 53.3 ± 7.0 |
| Fasting C-peptide level (nmol/L)* | 0.89 ± 0.11 | 0.46 ± 0.10 |
| Fasting insulin level (pmol/L)* | 24.3 ± 4.6 | 19.7 ± 3.0 |
| Aspirin, n (%) | 29 (55.8) | 30 (53.7) |
| ACEI, n (%) | 10 (19.2) | 9 (16.1) |
| ARB, n (%) | 4 (7.7) | 6 (10.7) |
| CCB, n (%) | 5 (9.6) | 4 (7.1) |
| Statins, n (%) | 16 (30.8) | 17 (30.4) |
| IFG, n (%)* | 40 (76.9) | 46 (82.1) |
*p < 0.05